Ebru Kocatürk Güllü
Research Subjects
Research Interests
Ebru Kocatürk Güllü has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Güzin Zeren Öztürk
Health Sciences University Şişli Hamidiye Etfal Training and Research Hospital
1 shared publication - Yağmur Gökseven Arda
Department of Family Medicine, İstanbul Şişli Hamidiye Etfal Training and Research Hospital, University of Health Sciences, İstanbul, Türkiye
1 shared publication
Latest Publications
- Open Access
- 30 September 2025
- Published by Turkish Family Physicians Association in Turkish Journal of Family Practice
- Vol. 29 (3) , 167-177
Effectiveness of pharmacological smoking cessation treatments: a retrospective comparison of common methods
Objective: This study aimed to compare the short-term (three-month) effectiveness of three smoking cessation therapies, bupropion, nicotine patch, and cytisine, and to retrospectively evaluate the impact of cytisine therapy on craving reduction and its side effect profile under routine clinical practice conditions. Methods: A total of 565 individuals who presented to the Smoking Cessation Outpatient Clinic between February 2024 and January 2025 and completed treatment with either cytisine, bupropion, or nicotine patch were included in the study. Demographic characteristics, chronic disease status, Fagerström Test for Nicotine Dependence (FTND) scores, and smoking cessation outcomes were assessed to compare treatment success across the three therapies. Among patients treated with cytisine, early craving reduction and reported side effects during the first week were recorded and analyzed in relation to cessation outcomes. Statistical significance was set at p
- 30 September 2025
- Published by Turkish Family Physicians Association in Turkish Journal of Family Practice
- Vol. 29 (3) , 167-177
Open AccessEffectiveness of pharmacological smoking cessation treatments: a retrospective comparison of common methods
Objective: This study aimed to compare the short-term (three-month) effectiveness of three smoking cessation therapies, bupropion, nicotine patch, and cytisine, and to retrospectively evaluate the impact of cytisine therapy on craving reduction and its side effect profile under routine clinical practice conditions. Methods: A total of 565 individuals who presented to the Smoking Cessation Outpatient Clinic between February 2024 and January 2025 and completed treatment with either cytisine, bupropion, or nicotine patch were included in the study. Demographic characteristics, chronic disease status, Fagerström Test for Nicotine Dependence (FTND) scores, and smoking cessation outcomes were assessed to compare treatment success across the three therapies. Among patients treated with cytisine, early craving reduction and reported side effects during the first week were recorded and analyzed in relation to cessation outcomes. Statistical significance was set at p